A first: Drug lowers heart risks by curbing inflammation


This Oct. 25, 2011 file photo shows the logo of Swiss pharmaceutical company Novartis AG on one of their buildings in Basel, Switzerland. According to results published Sunday, Aug. 27, 2017, for the first time, a drug has helped prevent heart attacks by curbing inflammation, a new and very different approach than lowering cholesterol, which has been the main focus for decades.



from Biotech News